Buchumschlag

Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma

OBJECTIVE: To report the effect of regional combination chemotherapy in a cohort of patients with inoperable pancreatic carcinoma treated with or without low-dose warfarin. MATERIAL AND METHODS: A retrospective analysis was performed on 180 patients with pancreatic carcinoma. Patients received one o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nakchbandi, Wes (VerfasserIn) , Müller, Herwart (VerfasserIn) , Singer, Manfred V. (VerfasserIn) , Löhr, J.-Matthias (VerfasserIn) , Nakchbandi, Inaam (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2006
In: Scandinavian journal of gastroenterology
Year: 2006, Jahrgang: 41, Heft: 9, Pages: 1095-1104
ISSN:1502-7708
DOI:10.1080/00365520600575720
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/00365520600575720
Volltext
Verfasserangaben:Wes Nakchbandi, Herwart Müller, Manfred V. Singer, Matthias Löhr & Inaam A. Nakchbandi

MARC

LEADER 00000caa a2200000 c 4500
001 1761552066
003 DE-627
005 20230426153135.0
007 cr uuu---uuuuu
008 210630s2006 xx |||||o 00| ||eng c
024 7 |a 10.1080/00365520600575720  |2 doi 
035 |a (DE-627)1761552066 
035 |a (DE-599)KXP1761552066 
035 |a (OCoLC)1341417803 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Nakchbandi, Wes  |d 1963-  |e VerfasserIn  |0 (DE-588)129877840  |0 (DE-627)482373601  |0 (DE-576)297882767  |4 aut 
245 1 0 |a Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma  |c Wes Nakchbandi, Herwart Müller, Manfred V. Singer, Matthias Löhr & Inaam A. Nakchbandi 
264 1 |c 2006 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe 
500 |a Gesehen am 30.06.2021 
520 |a OBJECTIVE: To report the effect of regional combination chemotherapy in a cohort of patients with inoperable pancreatic carcinoma treated with or without low-dose warfarin. MATERIAL AND METHODS: A retrospective analysis was performed on 180 patients with pancreatic carcinoma. Patients received one of seven regimens of chemotherapy. Unrelated to the type of chemotherapy, some patients received 1.25 mg warfarin daily. The primary end-point was median survival. RESULTS: Treatment with warfarin resulted in improved median survival from the start of regional therapy (warfarin versus no warfarin: 5.0 versus 2.3 months, n = 111 versus 69; p < 0.0001). This effect was not dependent on the type of chemotherapy used. Among the seven regimens examined, the one consisting of regional gemcitabine and mitomycin-C with systemic gemcitabine was associated with the longest median survival of 5.1 months from the start of regional therapy (p = 0.006) and 12.7 months from diagnosis. This regimen combined with warfarin was associated with improved median survival (7.1 months, n = 32). CONCLUSIONS: Treatment with low-dose warfarin improved survival irrespective of the chemotherapy received. Of the regimens examined, the combination of regional gemcitabine and mitomycin-C with systemic gemcitabine was associated with the longest survival time. Survival was increased further by the addition of warfarin. These data provide a rationale, based on safety and efficacy, for a definitive study on the use of warfarin and combined regional and systemic chemotherapy in patients with pancreatic carcinoma. 
650 4 |a Antibiotics, Antineoplastic 
650 4 |a Anticoagulants 
650 4 |a Carcinoma 
650 4 |a Deoxycytidine 
650 4 |a Dose-Response Relationship, Drug 
650 4 |a Drug Therapy, Combination 
650 4 |a Female 
650 4 |a Follow-Up Studies 
650 4 |a Humans 
650 4 |a Immunosuppressive Agents 
650 4 |a Injections, Intra-Arterial 
650 4 |a Male 
650 4 |a Middle Aged 
650 4 |a Mitomycin 
650 4 |a Pancreatic Neoplasms 
650 4 |a Retrospective Studies 
650 4 |a Ribonucleotide Reductases 
650 4 |a Survival Rate 
650 4 |a Treatment Outcome 
650 4 |a Warfarin 
700 1 |a Müller, Herwart  |e VerfasserIn  |4 aut 
700 1 |a Singer, Manfred V.  |d 1945-  |e VerfasserIn  |0 (DE-588)121081958  |0 (DE-627)081074069  |0 (DE-576)169905330  |4 aut 
700 1 |a Löhr, J.-Matthias  |e VerfasserIn  |0 (DE-588)13947241X  |0 (DE-627)611268973  |0 (DE-576)31199735X  |4 aut 
700 1 |a Nakchbandi, Inaam  |d 1967-  |e VerfasserIn  |0 (DE-588)142756881  |0 (DE-627)638931053  |0 (DE-576)188363874  |4 aut 
773 0 8 |i Enthalten in  |t Scandinavian journal of gastroenterology  |d Abingdon : Taylor & Francis Group, 1966  |g 41(2006), 9, Seite 1095-1104  |h Online-Ressource  |w (DE-627)302725571  |w (DE-600)1492631-3  |w (DE-576)088704866  |x 1502-7708  |7 nnas  |a Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma 
773 1 8 |g volume:41  |g year:2006  |g number:9  |g pages:1095-1104  |g extent:10  |a Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma 
856 4 0 |u https://doi.org/10.1080/00365520600575720  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210630 
993 |a Article 
994 |a 2006 
998 |g 142756881  |a Nakchbandi, Inaam  |m 142756881:Nakchbandi, Inaam  |d 50000  |e 50000PN142756881  |k 0/50000/  |p 1  |x j 
998 |g 13947241X  |a Löhr, J.-Matthias  |m 13947241X:Löhr, J.-Matthias  |d 60000  |d 61100  |e 60000PL13947241X  |e 61100PL13947241X  |k 0/60000/  |k 1/60000/61100/  |p 4 
998 |g 121081958  |a Singer, Manfred V.  |m 121081958:Singer, Manfred V.  |d 60000  |d 61100  |e 60000PS121081958  |e 61100PS121081958  |k 0/60000/  |k 1/60000/61100/  |p 3 
999 |a KXP-PPN1761552066  |e 3942561352 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma","title_sort":"Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinoma"}],"id":{"eki":["1761552066"],"doi":["10.1080/00365520600575720"]},"name":{"displayForm":["Wes Nakchbandi, Herwart Müller, Manfred V. Singer, Matthias Löhr & Inaam A. Nakchbandi"]},"physDesc":[{"extent":"10 S."}],"origin":[{"dateIssuedDisp":"2006","dateIssuedKey":"2006"}],"relHost":[{"id":{"issn":["1502-7708"],"eki":["302725571"],"zdb":["1492631-3"]},"pubHistory":["1.1966 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"9","volume":"41","pages":"1095-1104","year":"2006","extent":"10","text":"41(2006), 9, Seite 1095-1104"},"recId":"302725571","note":["Gesehen am 31.08.15"],"origin":[{"dateIssuedKey":"1966","publisherPlace":"Abingdon ; Oslo [u.a.] ; London [u.a.] ; London","publisher":"Taylor & Francis Group ; Scandinavian Univ. Press ; Taylor & Francis ; Informa Healthcare","dateIssuedDisp":"1966-"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"disp":"Effects of low-dose warfarin and regional chemotherapy on survival in patients with pancreatic carcinomaScandinavian journal of gastroenterology","title":[{"title_sort":"Scandinavian journal of gastroenterology","title":"Scandinavian journal of gastroenterology"}]}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","given":"Wes","display":"Nakchbandi, Wes","family":"Nakchbandi"},{"family":"Müller","display":"Müller, Herwart","roleDisplay":"VerfasserIn","role":"aut","given":"Herwart"},{"family":"Singer","display":"Singer, Manfred V.","role":"aut","roleDisplay":"VerfasserIn","given":"Manfred V."},{"display":"Löhr, J.-Matthias","role":"aut","roleDisplay":"VerfasserIn","given":"J.-Matthias","family":"Löhr"},{"family":"Nakchbandi","role":"aut","roleDisplay":"VerfasserIn","given":"Inaam","display":"Nakchbandi, Inaam"}],"language":["eng"],"note":["Elektronische Reproduktion der Druck-Ausgabe","Gesehen am 30.06.2021"],"recId":"1761552066","type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a NAKCHBANDIEFFECTSOFL2006 

Ähnliche Einträge